Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 1/20 | 0.47 |
| ▸ | ACHE | P22303 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.46 |
| ▸ | TSHR | P16473 | 4/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 10/20 | 0.44 |
| ▸ | MAPT | P10636 | 9/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.44 |
| ▸ | RECQL | P46063 | 7/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.44 |
| ▸ | ADRB2 | P07550 | 5/20 | 0.44 |
| ▸ | APEX1 | P27695 | 4/20 | 0.44 |
| ▸ | MEN1 | O00255 | 4/20 | 0.44 |
| ▸ | ADRB1 | P08588 | 4/20 | 0.44 |
| ▸ | ADRB3 | P13945 | 4/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.44 |
| ▸ | MTOR | P42345 | 4/20 | 0.44 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.44 |
| ▸ | DRD2 | P14416 | 3/20 | 0.44 |
| ▸ | ADRA1D | P25100 | 3/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 3/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28957735 | 0.85 | TDP1 (0.50) | BCHEACHECYP3A4TSHRTDP1 | |
| SCHEMBL9580100 | 0.83 | TDP1 (0.56) | BCHEACHECYP3A4TSHRTDP1 | |
| Hydrochloric Acid SCHEMBL30252423 | 0.81 | KDM4E (0.55) | BCHEACHECYP3A4TSHRTDP1 | |
| SCHEMBL17253835 | 0.81 | TDP1 (0.44) | CYP3A4TSHRTDP1MAPTKDM4E | |
| SCHEMBL13715489 | 0.80 | TDP1 (0.62) | BCHEACHECYP3A4TSHRTDP1 | |
| SCHEMBL30849924 | 0.80 | TDP1 (0.62) | BCHEACHECYP3A4TSHRTDP1 | |
| SCHEMBL22971740 | 0.80 | TDP1 (0.62) | BCHEACHECYP3A4TSHRTDP1 | |
| SCHEMBL13425968 | 0.78 | ADRB2 (0.64) | BCHEACHECYP3A4TSHRTDP1 | |
| SCHEMBL13425979 | 0.78 | ADRB2 (0.64) | BCHEACHECYP3A4TSHRTDP1 | |
| SCHEMBL29999118 | 0.78 | BCHE (0.51) | BCHEACHECYP3A4TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015169980-A1 | BACTERIAL STRAINS AND THE USES THEREOF IN ACYLATION AND/OR DEACYLATION REACTIONS | UNIVERSIDAD DE SEVILLA (ES) | 2015-11-12 | — | — | WO | disclosed |
| US-6906100-B2 | Compounds and compositions derived from olives and methods of the use thereof | LAVIPHARM S.A. (GR) | 2005-06-14 | — | — | US | disclosed |
| EP-1474130-A2 | USE OF COMPOUNDS AND COMPOSITIONS DERIVED FROM OLIVES FOR PROTECTING CELLS AGAINST DNA DAMAGE | LAVIPHARM S.A. (GR) | 2004-11-10 | — | — | EP | disclosed |
| US-20030185921-A1 | COMPOUNDS AND COMPOSITIONS DERIVED FROM OLIVES AND METHODS OF USE THEREOF | THALLIUM HOLDING COMPANY, LLC | 2003-10-02 | — | — | US | disclosed |
| WO-2003066034-A2 | USE OF COMPOUNDS AND COMPOSITIONS DERIVED FORM OLIVES FOR PROTECTING CELLS AGAINST DNA DAMAGE | LAVIPHARM S.A. (GR) | 2003-08-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030185921-A1 | COMPOUNDS AND COMPOSITIONS DERIVED FROM OLIVES AND METHODS OF USE THEREOF | OGG1, SOD3, LIG3 | BCHE 2500/4885ACHE 899/4885CYP3A4 4148/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.